We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Inhibrx
INBX
$1.2B
| $330K | ﹤0.01% |
+21,066
| New | +$296K |
|
3377
Clearwater Paper
CLW
$271M
| $329K | ﹤0.01% |
11,541
+5,937
| +106% | +$232K |
|
3378
Integer Holdings
ITGR
$3.35B
| $327K | ﹤0.01% |
+2,516
| New | +$308K |
|
3379
ArcBest
ARCB
$3.44B
| $326K | ﹤0.01% |
3,002
-12,165
| -80% | -$1.34M |
|
3380
Ouster
OUST
$2.29B
| $325K | ﹤0.01% |
+51,612
| New | +$490K |
|
3381
American Coastal Insurance
ACIC
$498M
| $325K | ﹤0.01% |
28,829
+1,998
| +7% | +$22.3K |
|
|
TPC
3382
Tutor Perini Cor
TPC
$4.57B
| $325K | ﹤0.01% |
11,962
-103,758
| -90% | -$2.37M |
|
3383
Fulgent Genetics
FLGT
$559M
| $325K | ﹤0.01% |
+14,949
| New | +$334K |
|
3384
Interface
TILE
$1.91B
| $324K | ﹤0.01% |
+17,075
| New | +$294K |
|
3385
MoonLake Immunotherapeutics
MLTX
$1.59B
| $323K | ﹤0.01% |
6,402
-938
| -13% | -$44K |
|
3386
Nabors Industries
NBR
$1.23B
| $322K | ﹤0.01% |
+4,996
| New | +$385K |
|
|
CNTA
3387
DELISTED
Centessa Pharmaceuticals
CNTA
| $322K | ﹤0.01% |
+20,121
| New | +$246K |
|
|
FITB
3388
CALL
Fifth Third Bancorp
FITB
$52B
| $321K | ﹤0.01% |
+7,500
| New | +$305K |
|
3389
Bank of Montreal
BMO
$125B
| $321K | ﹤0.01% |
3,562
-25,005
| -88% | -$2.13M |
|
3390
Center Bancorp
CNOB
$1.63B
| $321K | ﹤0.01% |
+12,825
| New | +$295K |
|
|
PSTX
3391
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $321K | ﹤0.01% |
112,265
+29,628
| +36% | +$91.7K |
|
3392
NerdWallet
NRDS
$584M
| $319K | ﹤0.01% |
25,134
+4,092
| +19% | +$54.1K |
|
3393
Universal Electronics
UEIC
$57.2M
| $319K | ﹤0.01% |
34,534
+14,501
| +72% | +$146K |
|
|
CMBT
3394
CMB.TECH NV
CMBT
$4.57B
| $318K | ﹤0.01% |
19,146
+3,216
| +20% | +$52.9K |
|
3395
CALL
Hartford Financial Services
HIG
$38.5B
| $318K | ﹤0.01% |
+2,700
| New | +$296K |
|
3396
CALL
Burlington
BURL
$22B
| $316K | ﹤0.01% |
1,200
-200
| -14% | -$51.8K |
|
3397
Editas Medicine
EDIT
$399M
| $316K | ﹤0.01% |
92,713
-601,467
| -87% | -$2.62M |
|
3398
Fulcrum Therapeutics
FULC
$248M
| $315K | ﹤0.01% |
88,130
+63,613
| +259% | +$472K |
|
3399
Inter&Co
INTR
$2.34B
| $314K | ﹤0.01% |
47,212
+9,504
| +25% | +$65.7K |
|
3400
CALL
Nasdaq
NDAQ
$51.5B
| $314K | ﹤0.01% |
+4,300
| New | +$294K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.